Tony Berberabe, MPH

The anti-PD-1 monoclonal antibody pidilizumab showed promising clinical activity and was safely administered to patients with diffuse large B-cell lymphoma after autologous hematopoietic stem-cell transplantation.

The Office of the National Coordinator for Health Information Technology has released a set of guides and interactive tools to help medical practices improve their use of electronic health records.

Researchers in the Department of Radiation Oncology at the University of North Carolina Hospitals found that almost one-third of low-risk and almost one-half of intermediate-risk prostate cancer patients received a staging bone scan.

A new report about healthcare provider experience with clinical decision support tools says the systems are not integrated enough to deliver the strategic direction providers are looking for.

The Centers for Medicare & Medicaid Services will make public a once previously confidential database of Medicare claims.

Single-agent neoadjuvant capecitabine combined with radiation therapy demonstrated similar outcomes as previously established standards of care for patients with stage II or stage III rectal cancer.

A survey of 46 representatives from accountable care organizations (ACOs) indicates that critical gaps remain in the organizations' ability to support, manage, and ensure appropriate medication use.

Patient care is shifting from inpatient to outpatient settings, especially in oncology.

With the October deadline for ICD-10 transition looming, now might be the time to consider integrating current electronic health records systems with clinically-driven revenue cycle management (RCM) software.

The transition to ICD-10 is likely to cost your practice both time and money, making a smooth implementation process all the more important.

San Diego-based Ambit Biosciences is staking its success on the kinome, a set of protein kinases in the genome and an important source for targeted therapies in oncology.

Provider-based research networks (PBRNs) make clinical trials available to community-based practices.

Patients who undergo androgen deprivation therapy (ADT) to manage advanced prostate cancer will often face the prospect of a potentially dangerous testosterone surge before the downregulation of leuteinizing hormone (LH) secretion occurs and, within about 3 weeks, testosterone drops to castration-like levels.

Although the changeover to using ICD-10 billing codes won't be mandatory until October 1, 2014, there are many coding changes to consider starting on January 1. Specifically, the reimbursement rate for some genetic testing and imaging involving breast cancer will see significant changes.

As new cancer therapies have prolonged life, an interesting question has arisen among community oncologists: "Is it better to transfer long-term cancer survivors to general practitioners or develop clinics for long-term survivors within cancer centers?"

The first oncology-specific accountable care organization (ACO) reported more than a 2% savings in its first year of existence.

The tiny "raise" touted in the latest temporary fix to Medicare's Sustainable Growth Rate, which was wrapped inside the bipartisan budget deal headed to President Obama's desk, is anything but good news for oncologists.

The current American health care payment system that is tied to high-cost procedures, including cancer care, demonstrates the system's shortfalls and inefficiencies.

The use of accountable care organizations (ACOs) among the Medicare population is growing in use. How well beneficiaries with high-risk, high cost conditions such as cancer, will fare under an ACO have not been determined, but a new study from the Dartmouth Institute for Health Policy and Clinical Practice suggests the possibility of significant reduction in Medicare spending.

Oncologists and other specialists who prescribe specialty medications are highly satisfied with their specialty pharmacy, but that satisfaction doesn't translate to some traditional drugstores.

Some radiation oncologists may breathe a little easier for now because the CMS has decided not to cap certain freestanding radiation oncology reimbursements in its Physician Fee Schedule Final Rule.

Medical practices are getting squeezed from all sides and are finding it difficult to stay financially solvent.

To respond to the growing demand in cancer services that the existing cancer center was experiencing, Wake Forest Baptist Medical Center is expanding its comprehensive cancer center to help patients cope with the daunting challenges of cancer diagnosis and treatment.

The Centers for Medicare & Medicaid Services finalized physician payment rates and policies for 2014.

After a period of relative stability from 1991 to 2004, oncology practices can expect a continued drop in drug revenue in 2014, according to findings of the National Practice Benchmark (NBP) issued by Oncology Metrics.

The American College of Radiology (ACR) has issued new and updated evidence-based guidelines to assist oncologists when ordering exams and ensure that patients get the correct scan or therapy for the right indication.

The hematology-oncology division of an academic health center participated in a pilot physician compensation exercise using variable compensation incentives with group-specific targets based on prior below-average performance.

Many patients being treated with mTOR inhibitors experience dermatologic-related adverse events.

A new consortium of payers, clinicians, patients, and pharmaceutical companies are developing recommendations to help generate evidence-based guidelines to define coverage and develop payment decisions for treating cancer.

Two large cohort studies, suggest that the costly scan is being overused in women who won't benefit from it and underused in women who could gain benefit from it.